Variant report
Variant | esv14828 |
---|---|
Chromosome Location | chr5:107794869-107795891 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371766288 | chr5:107795217-107795218 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs79770230 | chr5:107795228-107795229 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs888749 | chr5:107795230-107795231 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs191997503 | chr5:107795298-107795299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10043553 | chr5:107795317-107795318 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs34273239 | chr5:107795319-107795320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs561619407 | chr5:107795331-107795332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114325578 | chr5:107795344-107795345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547352836 | chr5:107795357-107795358 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs183338987 | chr5:107795397-107795398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539516276 | chr5:107795411-107795412 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
12 | rs1078831 | chr5:107795432-107795433 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs552718704 | chr5:107795434-107795435 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
14 | rs557067716 | chr5:107795445-107795446 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
15 | rs6882933 | chr5:107795454-107795455 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs140219478 | chr5:107795503-107795504 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
17 | rs1106925 | chr5:107795511-107795512 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs567698449 | chr5:107795512-107795513 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
19 | rs10043600 | chr5:107795557-107795558 | Enhancers Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs534222186 | chr5:107795571-107795572 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
21 | rs554117251 | chr5:107795574-107795575 | Enhancers Active TSS | n/a | n/a | Overlapped CNVs | n/a |
22 | rs186972118 | chr5:107795626-107795627 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
23 | rs546285558 | chr5:107795686-107795687 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
24 | rs137916518 | chr5:107795714-107795715 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
25 | rs76719632 | chr5:107795721-107795722 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189782652 | chr5:107795742-107795743 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541588386 | chr5:107795747-107795748 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
28 | rs561680022 | chr5:107795752-107795753 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
29 | rs888750 | chr5:107795755-107795756 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs540716207 | chr5:107795775-107795776 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
31 | rs182143977 | chr5:107795782-107795783 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
32 | rs55857894 | chr5:107795787-107795788 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188064436 | chr5:107795799-107795800 | Enhancers Active TSS Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569741880 | chr5:107795804-107795805 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs1421973 | chr5:107795811-107795812 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs371627310 | chr5:107795836-107795837 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs112070335 | chr5:107795857-107795858 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548786950 | chr5:107795889-107795890 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16773561 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:107795200-107795800 | Enhancers | Fetal Lung | lung |
2 | chr5:107795200-107796000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr5:107795200-107796000 | Enhancers | Cortex derived primary cultured neurospheres | brain |
4 | chr5:107795400-107795600 | Enhancers | HSMMtube | muscle |
5 | chr5:107795400-107795800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr5:107795400-107795800 | Active TSS | Brain Angular Gyrus | brain |
7 | chr5:107795400-107796200 | Enhancers | Brain Germinal Matrix | brain |
8 | chr5:107795600-107795800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr5:107795600-107795800 | Flanking Active TSS | Brain Cingulate Gyrus | brain |
10 | chr5:107795800-107796800 | Weak transcription | HSMMtube | muscle |
11 | chr5:107795800-107797000 | Weak transcription | Fetal Lung | lung |